Annals of Emergency Medicine
Volume 39, Issue 3 , Pages 273-286 , March 2002

The role of activated charcoal and gastric emptying in gastrointestinal decontamination: A state-of-the-art review

Received 27 September 1999 ,Revised 19 October 2001 ,Accepted 2 December 2001.

References 

  1. Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:711–719
  2. Hoffman R. Importance of gastrointestinal decontamination. Online J Med Toxicol [serial online]. 1999;2:5
  3. Whyte IM, Buckley NA. Progress in clinical toxicology: from case reports to toxicoepidemiology. Med J Aust. 1995;163:340–341
  4. Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:721–741
  5. Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:699–709
  6. Perrone J, Hoffman RS, Goldfrank LR. Special considerations in gastrointestinal decontamination. Emerg Med Clin North Am. 1994;12:285–299
  7. Shannon M. Ingestion of toxic substances by children. N Engl J Med. 2000;342:186–191
  8. Hantsch C, Seger D, Meredith T. New thinking on gastrointestinal decontamination. Pediatr Emerg Med Reports. 1998;3:11–18
  9. Manoguerra AS. Gastrointestinal decontamination after poisoning. Where is the science?. Crit Care Clin. 1997;13:709–725
  10. Perry H, Shannon M. Emergency department gastrointestinal decontamination. Pediatr Ann. 1996;25:19–26
  11. Tenenbein M, Shannon M. The poisoned patient: is gastrointestinal decontamination all washed up? Two responses. Pediatr Emerg Care. 1998;14:380–381
  12. Barceloux D, McGuigan M, Hartigan-Go K. Position statement: cathartics. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:743–752
  13. Tenenbein M. Position statement: whole bowel irrigation. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:753–762
  14. Derlet RW, Albertson TE. Potentiation of cocaine toxicity with calcium channel blockers. Am J Emerg Med. 1989;7:464–468
  15. Kirk M, Peterson J, Kulig K, et al.  Acetaminophen overdose in children: a comparison of ipecac versus activated charcoal versus no gastrointestinal decontamination [abstract]. Ann Emerg Med. 1991;20:472–473
  16. Bond GR, Requa RK, Krenzelok EP, et al.  Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population. Ann Emerg Med. 1993;22:1403–1407
  17. Bond GR. Home use of syrup of ipecac is associated with a reduction in pediatric emergency department visits. Ann Emerg Med. 1995;25:338–343
  18. Buckley NA, Whyte IM, O'Connell DL, et al.  Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol. 1999;37:753–757
  19. Eddleston M, Buckley N. Paracetamol (acetaminophen) poisoning. In:  Barton S,  Adams C,  Cuervo Amore LG, et al. editor. Clinical Evidence. London, England: BMJ Publishing Group; December 2000;p. 775–780
  20. Kulig K, Bar-Or D, Cantrill SV, et al.  Management of acutely poisoned patients without gastric emptying. Ann Emerg Med. 1985;14:562–567
  21. Merigian KS, Woodard M, Hedges JR, et al.  Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med. 1990;8:479–483
  22. Albertson TE, Derlet RW, Foulke GE, et al.  Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann Emerg Med. 1989;18:56–59
  23. Pond SM, Lewis-Driver DJ, Williams GM, et al.  Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust. 1995;163:345–349
  24. Moll J, Kerns W, Tomaszewski C, et al.  Incidence of aspiration pneumonia in intubated patients receiving activated charcoal. J Emerg Med. 1999;17:279–283
  25. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med. 1991;20:648–651
  26. Czajka PA, Russell SL. Nonemetic effects of ipecac syrup. Pediatrics. 1985;75:1101–1104
  27. Sabga E, Dick A, Lertzman M, et al.  Direct administration of charcoal into the lung and pleural cavity. Ann Emerg Med. 1997;30:695–697
  28. Harris C, Filandrinos D. Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med. 1993;22:1470–1473
  29. Elliot C, Colby T, Hicks H. Charcoal lung: bronchiolitis obliterans after aspiration of activated charcoal. Chest. 1989;96:672–674
  30. Menzies D, Busutill A, Prescott L. Fatal pulmonary aspiration of oral activated charcoal. BMJ. 1988;297:459–460
  31. Arnold TC, Willis BH, Xiao F, et al.  Aspiration of activated charcoal elicits an increase in lung microvascular permeability. J Toxicol Clin Toxicol. 1999;37:9–16
  32. Thomas B, Cummin D, Falcone R. Accidental pneumothorax from nasogastric tube [letter]. N Engl J Med. 1996;335:1325
  33. Mariani PJ, Pook N. Gastrointestinal tract perforation with charcoal peritoneum complicating orogastric intubation and lavage. Ann Emerg Med. 1993;22:606–609
  34. Scalzo A, Tominack R, Thompson M. Malposition of pediatric gastric lavage tubes demonstrated radiographically. J Emerg Med. 1992;10:581–586
  35. Wolsey BA, McKinney PE. Does transportation by ambulance decrease time to gastrointestinal decontamination after overdose?. Ann Emerg Med. 2000;35:579–584
  36. Gomez HF, McClafferty HH, Flory D, et al.  Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med. 1997;30:587–592
  37. Decker WJ, Combs HF, Corby DG. Adsorption of drugs and poisons by activated charcoal. Toxicol Appl Pharmacol. 1968;13:454–460
  38. Gades NM, Chyka PA, Virgous CK, et al.  Influence of activated charcoal on the absorption of ferrous sulfate in rats [abstract]. J Toxicol Clin Toxicol. 2000;38:528
  39. Favin FD, Klein-Schwartz W, Oderda GM, et al.  In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol. 1988;26:443–450
  40. Linakis JG, Lacouture PG, Eisenberg MS, et al.  Administration of activated charcoal or sodium polystyrene sulfonate (kayexalate) as gastric decontamination for lithium intoxication: an animal model. Pharmacol Toxicol. 1989;65:387–389
  41. Wallace KL, Curry SC, LoVecchio F, et al.  Effect of magnesium hydroxide on iron absorption after ferrous sulfate [letter]. Ann Emerg Med. 1999;34:685–687
  42. Snyder BK, Clark RF. Effect of magnesium hydroxide administration on iron absorption after a supratherapeutic dose of ferrous sulfate in human volunteers: a randomized controlled trial. Ann Emerg Med. 1999;33:400–405
  43. Belanger DR, Tierney MG, Dickinson G. Effect of sodium polystyrene sulfonate on lithium bioavailability. Ann Emerg Med. 1992;21:1312–1315
  44. Tomaszewski C, Musso C, Pearson JR, et al.  Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. Ann Emerg Med. 1992;21:1308–1311
  45. Roberge RJ, Martin TG, Schneider SM. Use of sodium polystyrene sulfonate in a lithium overdose. Ann Emerg Med. 1993;22:1911–1915
  46. Tenenbein M, Cohen S, Sitar DS. Whole bowel irrigation as a decontamination procedure after acute drug overdose. Arch Intern Med. 1987;147:905–907
  47. Everson GW, Bertaccini EJ, O'Leary J. Use of whole bowel irrigation in an infant following iron overdose. Am J Emerg Med. 1991;9:366–369
  48. Smith SW, Ling LJ, Halstenson CE. Whole-bowel irrigation as a treatment for acute lithium overdose. Ann Emerg Med. 1991;20:536–539
  49. Tenenbein M. Whole bowel irrigation in iron poisoning. J Pediatr. 1987;111:142–145
  50. Bosse GM, Barefoot JA, Pfeifer MP, et al.  Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med. 1995;13:203–209
  51. El-Bahie N, Allen EM, Williams AJ, et al.  The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. Br J Clin Pharmacol. 1985;19:836–838
  52. Saetta JP, March S, Gaunt ME, et al.  Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus?. J Royal Soc Med. 1991;84:274–276
  53. Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch Intern Med. 1984;144:48–52
  54. Corby DG, Decker WJ, Moran MJ, et al.  Clinical comparison of pharmacologic emetics in children. Pediatrics. 1968;42:361–364
  55. Boxer L, Anderson FP, Rowe DS. Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J Pediatr. 1969;74:800–803
  56. Decker WJ, Shpall RA, Corby DG, et al.  Inhibition of aspirin absorption by activated charcoal and apomorphine. Clin Pharmacol Ther. 1969;10:710–713
  57. Levy G, Houston JB. Effect of activated charcoal on acetaminophen absorption. Pediatrics. 1976;58:432–435
  58. Dawling S, Crome P, Braithwaite R. Effect of delayed administration of activated charcoal on Nortriptyline absorption. Eur J Clin Pharmacol. 1978;14:445–447
  59. Comstock EG, Boisaubin EV, Comstock BS, et al.  Assessment of the efficacy of activated charcoal following gastric lavage in acute drug emergencies. J Toxicol Clin Toxicol. 1982;19:149–165
  60. Sketris IS, Mowry JB, Czajka PA, et al.  Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal. J Clin Pharmacol. 1982;22:59–64
  61. Easom JM, Caraccio TR, Lovejoy FH. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Clin Pharm. 1982;1:154–156
  62. Neuvonen PJ, Vartiainen M, Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol. 1983;24:557–562
  63. Galinsky R, Levy G. Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate. J Toxicol Clin Toxicol. 1984;22:21–30
  64. Tandberg D, Diven BG, McLeod JW. Ipecac-induced emesis versus gastric lavage: a controlled study in normal adults. Am J Emerg Med. 1986;4:205–209
  65. Auerbach PS, Osterloh J, Braun O, et al.  Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac. Ann Emerg Med. 1986;15:692–698
  66. Tenenbein M, Cohen S, Sitar DS. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med. 1987;16:838–841
  67. Knadler MP, Bergstrom RF, Callaghan JT, et al.  Absorption studies of the H2-blocker nizatidine. Clin Pharmacol Therap. 1987;42:514–520
  68. McNamara RM, Aaron CK, Gemborys M, et al.  Sorbital catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose. Ann Emerg Med. 1988;17:243–246
  69. Danel V, Henry JA, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. BMJ. 1988;296:1507
  70. Tandberg D, Murphy LC. The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am J Emerg Med. 1989;7:267–270
  71. Dillon EC, Wilton JH, Barlow JC, et al.  Large surface area activated charcoal and the inhibition of aspirin absorption. Ann Emerg Med. 1989;18:547–552
  72. Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med. 1990;19:654–656
  73. Kivisto KT, Neuvonen PJ. Effect of activated charcoal on the absorption of amiodarone. Hum Exper Toxicol. 1991;10:327–329
  74. Rose SR, Gorman RL, Oderda GM, et al.  Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal. Ann Emerg Med. 1991;20:1064–1068
  75. Saetta JP, Quinton DN. Residual gastric content after gastric lavage and ipecacuanha-induced emesis in self-poisoned patients: an endoscopic study. J Royal Soc Med. 1991;84:35–38
  76. Young WF, Bivins HG. Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis. Ann Emerg Med. 1993;22:1423–1427
  77. Olsen KM, Ma FH, Ackerman BH, et al.  Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal. Pharmacotherapy. 1993;13:229–232
  78. Shrestha M, George J, Chiu MJ, et al.  A comparison of three gastric lavage methods using the radionuclide gastric emptying study. J Emerg Med. 1996;14:413–418
  79. Laine K, Kivisto KT, Pelttari S, et al.  The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration. Pharmacol Toxicol. 1996;79:270–273
  80. Laine K, Kivisto KT, Laakso I, et al.  Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol. 1997;43:29–33
  81. Laine K, Kivisto KT, Neuvonen PJ. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. J Toxicol Clin Toxicol. 1997;35:263–268
  82. Saincher A, Sitar DS, Tenenbein M. Efficacy of ipecac during the first hour after drug ingestion in human volunteers. J Toxicol Clin Toxicol. 1997;35:609–615
  83. Lapatto-Reiniluoto O, Kivisto KT, Neuvonen PJ. Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram. Br J Clin Pharmacol. 1999;48:148–153
  84. Yeates PJ, Thomas SH. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Br J Clin Pharmacol. 2000;49:11–14
  85. Rosenberg PJ, Livingstone DJ, McLellan BA. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal. Ann Emerg Med. 1988;17:681–683
  86. Neuvonen PJ, Kivisto K, Hirvisalo EL. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Br J Clin Pharmacol. 1988;25:229–233

☆ Editor's note: This article continues a series of special contributions addressing state-of-the-art techniques, topics, or concepts. State-of-the-art articles will be featured in Annals on a regular basis in the next several volumes.

☆☆ Reprints not available from the author. Address for correspondence: G. Randall Bond, MD, Department of Emergency Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229, 513-636-2744, fax 513-636-7967; E-mail: randy.bond@chmcc.org

PII: S0196-0644(02)07065-8

doi: 10.1067/mem.2002.122058

Annals of Emergency Medicine
Volume 39, Issue 3 , Pages 273-286 , March 2002

Article Tools

* Image Usage & Resolution